OBJECTIVE: To assess the effectiveness of blood pressure self-monitoring at home in front of 24-h blood pressure ambulatory measurement in isolated clinical hypertension diagnosis. DESIGN: Comparative study of repeated measurements of self-monitoring home BP and 24-h ambulatory BP measurement in a hypertensive patients sample. SETTING AND SUBJECTS TO STUDY: Mild-moderate essential hypertensive patients newly diagnosed or previously diagnosed in which suspect isolated clinical hypertension (BP>140/90 mm Hg in clinical setting repeatedly). It needs a sample of 182 hypertensive patients seen at urban primary health care. PRINCIPAL MEASUREMENTS: We compute the isolated clinical hypertension prevalence, the sensibility, specificity and positive and negative predictive values, with 95% confidence intervals. DISCUSSION: Prove the effectiveness of blood pressure self-monitoring at home in insolated clinical hypertension diagnosis, can involve an important cost saving for health care system as in hypertensive patient management (medicines and office visits), as in diagnosis equipment.
OBJECTIVE: To assess the effectiveness of blood pressure self-monitoring at home in front of 24-h blood pressure ambulatory measurement in isolated clinical hypertension diagnosis. DESIGN: Comparative study of repeated measurements of self-monitoring home BP and 24-h ambulatory BP measurement in a hypertensivepatients sample. SETTING AND SUBJECTS TO STUDY: Mild-moderate essential hypertensivepatients newly diagnosed or previously diagnosed in which suspect isolated clinical hypertension (BP>140/90 mm Hg in clinical setting repeatedly). It needs a sample of 182 hypertensivepatients seen at urban primary health care. PRINCIPAL MEASUREMENTS: We compute the isolated clinical hypertension prevalence, the sensibility, specificity and positive and negative predictive values, with 95% confidence intervals. DISCUSSION: Prove the effectiveness of blood pressure self-monitoring at home in insolated clinical hypertension diagnosis, can involve an important cost saving for health care system as in hypertensivepatient management (medicines and office visits), as in diagnosis equipment.
Authors: Elly Den Hond; Hilde Celis; Robert Fagard; Louis Keary; Marc Leeman; Eoin O'Brien; Guy Vandenhoven; Jan A Staessen Journal: J Hypertens Date: 2003-04 Impact factor: 4.844
Authors: Juan Diego Mediavilla García; José Mario Sabio; Pedro Luis Carrillo Alascio; Celia Fernández Torres; Luis Aliaga Martínez; Juan Jiménez-Alonso Journal: Med Clin (Barc) Date: 2002-10-05 Impact factor: 1.725
Authors: M A Martínez; J García-Puig; J C Martín; P Guallar-Castillón; A Aguirre de Cárcer; A Torre; E Armada; A Nevado; R S Madero Journal: Am J Hypertens Date: 1999-03 Impact factor: 2.689
Authors: J Divisón; A Puras; C Sanchis; L Artigao; J López Abril; E López De Coca; J Massó; B Rodríguez Paños Journal: Aten Primaria Date: 2001-03-31 Impact factor: 1.137
Authors: Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella Journal: JAMA Date: 2003-05-14 Impact factor: 56.272
Authors: S D Pierdomenico; A Mezzetti; D Lapenna; M D Guglielmi; M Mancini; L Salvatore; T Antidormi; F Costantini; F Cuccurullo Journal: Eur Heart J Date: 1995-05 Impact factor: 29.983